Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Oct;46(4):593–600. doi: 10.1038/bjc.1982.243

Immunity in Hodgkin's disease: status after 5 years' remission.

B W Hancock, L Bruce, M D Whitham, I R Dunsmore, A M Ward, J Richmond
PMCID: PMC2011201  PMID: 7138765

Abstract

Immunological indices have been reassessed in 27 patients in remission from Hodgkin's disease for 5 years after treatment and the findings correlated with initial treatment and splenectomy status. Neutrophil counts were lower and lymphocyte and monocyte counts higher at 5 years' remission than at presentation; the increases in lymphocyte count were mainly a feature of the splenectomized patients. Neutrophil function (nitro-blue tetrazolium) was unchanged in remission but cellular immunity (leucocyte migration inhibition and lymphocyte transformation) was depressed at 5 years and progressive falls in serum immunoglobulins were noted. Low values of IgG and IgM were particularly found in patients who had splenectomy and chemotherapy; there was however no excess of infections in this small group.

Full text

PDF
593

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorkholm M., Holm G., Mellstedt H. Immunologic profile of patients with cured Hodgkin's disease. Scand J Haematol. 1977 May;18(5):361–368. doi: 10.1111/j.1600-0609.1977.tb02090.x. [DOI] [PubMed] [Google Scholar]
  2. Björkholm M., Holm G., Mellstedt H. Persisting lymphocyte deficiences during remission in Hodgkin's disease. Clin Exp Immunol. 1977 Jun;28(3):389–393. [PMC free article] [PubMed] [Google Scholar]
  3. Fisher R. I., DeVita V. T., Jr, Bostick F., Vanhaelen C., Howser D. M., Hubbard S. M., Young R. C. Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. Ann Intern Med. 1980 May;92(5):595–599. doi: 10.7326/0003-4819-92-5-595. [DOI] [PubMed] [Google Scholar]
  4. Fisher R. I., Vanhaelen C., Bostick F. Increased sensitivity to normal adherent suppressor cells in untreated advanced Hodgkin's disease. Blood. 1981 May;57(5):830–835. [PubMed] [Google Scholar]
  5. Fuks Z., Strober S., Bobrove A. M., Sasazuki T., McMichael A., Kaplan H. S. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest. 1976 Oct;58(4):803–814. doi: 10.1172/JCI108532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hancock B. W., Bruce L., Dunsmore I. R., Ward A. M., Richmond J. Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission. Br J Cancer. 1977 Sep;36(3):347–354. doi: 10.1038/bjc.1977.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hancock B. W., Bruce L., Ward A. M., Richmond J. Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease. Br Med J. 1976 Feb 7;1(6005):313–315. doi: 10.1136/bmj.1.6005.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kun L. E., Johnson R. E. Hematologic and immunologic status in Hodgkin's disease 5 years after radical radiotherapy. Cancer. 1975 Nov;36(5):1912–1916. doi: 10.1002/1097-0142(197511)36:5<1912::aid-cncr2820360549>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  9. Park B. H., Fikrig S. M., Smithwick E. M. Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid. Lancet. 1968 Sep 7;2(7567):532–534. doi: 10.1016/s0140-6736(68)92406-9. [DOI] [PubMed] [Google Scholar]
  10. Schellekens P. T., Eijsvoogel V. P. Lymphocyte transformation in vitro. I. Tissue culture conditions and quantitative measurements. Clin Exp Immunol. 1968 Jul;3(6):571–584. [PMC free article] [PubMed] [Google Scholar]
  11. Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
  12. Steel C. M., Evans J., Smith M. A. The sheep-cell rosette: test on human peripheral blood lymyphocytes: an analysis of some analysis of some variable factors in the technique. Br J Haematol. 1974 Oct;28(2):245–251. doi: 10.1111/j.1365-2141.1974.tb06659.x. [DOI] [PubMed] [Google Scholar]
  13. Weitzman S. A., Aisenberg A. C., Siber G. R., Smith D. H. Impaired humoral immunity in treated Hodgkin's disease. N Engl J Med. 1977 Aug 4;297(5):245–248. doi: 10.1056/NEJM197708042970504. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES